Diagnostics

IP protection for diagnostic methods is critical in attracting companies wishing to invest in commercial development.  

The diagnostics attorneys at HGF provide strategic guidance for universities and research institutions, start-up companies, SMEs and large multinational biologics and pharmaceutical firms. The team’s expertise comprises significant expertise on EPO drafting and prosecution strategies in this specialist field, as well as deep knowledge of the changing multijurisdictional legal landscape on patent eligibility of diagnostic methods, along with products isolated from nature.  

Many of the large team have in-house diagnostics backgrounds within specialist biotech and large pharmaceutical firms, and blend rich experience with considerable academic accomplishments to develop and deliver smart, multijurisdictional strategies. Areas of expertise span patent and trade mark protection, freedom-to-operate evaluation and strategy, and advice on supplementary protection certificates, licensing and opposition and appeals.

Latest updates

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

Searching for the distinctive

How to streamline the trade mark selection process by conducting effective, in-house ‘dirty searches’. Selecting the right trade mark for your new healthcare product is a critically important task. Consumers …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article
Event - 26th April 2021

World Intellectual Property Day 2021

World Intellectual Property Day is on 26th April. This year’s theme is IP & SME’s: Taking your ideas to market. World IP day 2021 shines a light on the critical role of …

Event details
Event - 18th May 2021

IP & data protection for alternative proteins: how to protect your products in the EU

‘IP & data protection for alternative proteins: how to protect your products in the EU’ webinar will be held on Tuesday 18th May. Join this webinar by BGP, HGF & …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our diagnostics specialists.